Capital International Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $365M | Sell |
1,949,177
-60,820
| -3% | -$11.4M | 2.56% | 6 |
|
|
2026
Q1 | $393M | Buy |
2,009,997
+1,903,426
| +1,786% | +$367M | 3.03% | 3 |
|
|
2025
Q4 | $19.6M | Sell |
106,571
-117,798
| -53% | -$20.7M | 0.15% | 153 |
|
|
2025
Q3 | $34.4M | Buy |
224,369
+9,029
| +4% | +$1.37M | 0.28% | 96 |
|
|
2025
Q2 | $30.1M | Buy |
215,340
+67,362
| +46% | +$9.44M | 0.29% | 95 |
|
|
2025
Q1 | $21.8M | Buy |
147,978
+1,819
| +1% | +$263K | 0.26% | 106 |
|
|
2024
Q4 | $19.2M | Buy |
146,159
+14,752
| +11% | +$2.07M | 0.23% | 117 |
|
|
2024
Q3 | $20.5M | Buy |
131,407
+1,443
| +1% | +$233K | 0.26% | 108 |
|
|
2024
Q2 | $20.3M | Buy |
129,964
+10,949
| +9% | +$1.65M | 0.27% | 102 |
|
|
2024
Q1 | $16.1M | Buy |
119,015
+17,729
| +18% | +$2.35M | 0.22% | 128 |
|
|
2023
Q4 | $13.6M | Buy |
101,286
+42,843
| +73% | +$5.57M | 0.21% | 135 |
|
|
2023
Q3 | $7.92M | Buy |
58,443
+1,146
| +2% | +$157K | 0.15% | 149 |
|
|
2023
Q2 | $8.2M | Buy |
57,297
+36,467
| +175% | +$5.37M | 0.15% | 156 |
|
|
2023
Q1 | $2.89M | Sell |
20,830
-12,678
| -38% | -$1.71M | 0.06% | 196 |
|
|
2022
Q4 | $4.54M | Sell |
33,508
-4,889
| -13% | -$613K | 0.1% | 171 |
|
|
2022
Q3 | $4.21M | Buy |
38,397
+21,111
| +122% | +$2.68M | 0.09% | 174 |
|
|
2022
Q2 | $2.28M | Buy |
17,286
+7,451
| +76% | +$978K | 0.03% | 217 |
|
|
2022
Q1 | $1.3M | Sell |
9,835
-8,241
| -46% | -$988K | 0.01% | 258 |
|
|
2021
Q4 | $2.11M | Buy |
18,076
+156
| +0.9% | +$18.4K | 0.02% | 258 |
|
|
2021
Q3 | $2.15M | Sell |
17,920
-415
| -2% | -$48.3K | 0.02% | 254 |
|
|
2021
Q2 | $2.2M | Sell |
18,335
-646
| -3% | -$70.9K | 0.02% | 260 |
|
|
2021
Q1 | $1.89M | Buy |
18,981
+5,313
| +39% | +$534K | 0.02% | 261 |
|
|
2020
Q4 | $1.37M | Buy |
13,668
+154
| +1% | +$16.3K | 0.01% | 255 |
|
|
2020
Q3 | $1.48M | Sell |
13,514
-3,510
| -21% | -$390K | 0.02% | 239 |
|
|
2020
Q2 | $1.8M | Sell |
17,024
-9,370
| -36% | -$968K | 0.02% | 215 |
|
|
2020
Q1 | $2.36M | Buy |
26,394
+3,175
| +14% | +$299K | 0.04% | 164 |
|
|
2019
Q4 | $2.31M | Sell |
23,219
-130
| -0.6% | -$12.2K | 0.03% | 164 |
|
|
2019
Q3 | $2.08M | Buy |
+23,349
| New | +$2.02M | 0.03% | 163 |
|
|
2017
Q4 | – | Sell |
-8,450
| Closed | -$573K | – | 160 |
|
|
2017
Q3 | $573K | Sell |
8,450
-10,350
| -55% | -$654K | 0.08% | 119 |
|
|
2017
Q2 | $1.28M | Buy |
18,800
+1,550
| +9% | +$101K | 0.18% | 95 |
|
|
2017
Q1 | $1.07M | Sell |
17,250
-1,050
| -6% | -$61.1K | 0.13% | 109 |
|
|
2016
Q4 | $1M | Buy |
18,300
+10,500
| +135% | +$596K | 0.12% | 114 |
|
|
2016
Q3 | $513K | Buy |
7,800
+950
| +14% | +$62.1K | 0.06% | 113 |
|
|
2016
Q2 | $414K | Buy |
6,850
+350
| +5% | +$20.3K | 0.05% | 117 |
|
|
2016
Q1 | $366K | Buy |
6,500
+1,050
| +19% | +$63.1K | 0.04% | 113 |
|
|
2015
Q4 | $370K | Buy |
5,450
+250
| +5% | +$16.4K | 0.03% | 116 |
|
|
2015
Q3 | $331K | Buy |
5,200
+2,800
| +117% | +$184K | 0.03% | 116 |
|
|
2015
Q2 | $153K | Buy |
2,400
+600
| +33% | +$41.1K | 0.01% | 125 |
|
|
2015
Q1 | $123K | Buy |
+1,800
| New | +$125K | 0.01% | 125 |
|
Other funds holding AZN
EP
IA
Capital International Inc's AZN Position: Q2 2026 in Review
Capital International Inc reduced its AstraZeneca (AZN) stake by 3% in Q2 2026, selling an estimated $11.4M and leaving 1,949,177 shares worth $365M. The position accounts for 2.56% of the portfolio, ranked #6.
Capital International Inc first reported a position in AZN in Q1 2015 and has held it in 39 quarters since. The position peaked at $393M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Capital International Inc held 1,949,177 shares of AstraZeneca worth $365M as of Q2 2026.
- Capital International Inc sold 60,820 AstraZeneca shares in Q2 2026, an estimated $11.4M.
- AstraZeneca made up 2.56% of Capital International Inc's portfolio in Q2 2026, its #6 holding.
- Capital International Inc first reported a position in AstraZeneca in Q1 2015 and has held it in 39 quarters since.
- Capital International Inc's AstraZeneca position peaked at $393M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.